T-O (am): 0.780 (08:59:00)
Last updated: 17:00
Select columns required and click "Update" to save your preferences
Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
06 Mar 23 | Q2 Jan 23 | 2 | 31 Jul 23 | 12.52 | 3.73 | 2.91 | 23.2% | 0.00 | 0.78 | 10.6% | 45.4% | ||||||||||
02 Dec 22 | Q1 Oct 22 | 1 | 31 Jul 23 | 11.31 | 2.25 | 2.00 | 17.7% | 0.00 | 0.54 | 52.7% | 252.3% | ||||||||||
13 Sep 22 | Q4 Jul 22 | 4 | 31 Jul 22 | 7.41 | 0.30 | 0.57 | 7.7% | 0.00 | 0.15 | 14.5% | 55.8% | ||||||||||
22 Jul 22 | Q3 Apr 22 | 3 | 31 Jul 22 | 6.47 | 1.47 | 1.29 | 19.9% | 0.00 | 0.34 |
EPS | 1.81 sen |
Trailing PE (Sector Median: 24.6) | 43.9 |
PEG | 0.97 |
Altman Z | 1.4 |
Beaver | 0.114 |
Current Ratio | 5.32 |
Debt-Equity (DE) Ratio | 0.31 |
FCF Yield | 0.02 % |
Revenue QoQ | 10.64 % |
Revenue YoY | 0% |
Profit QoQ | 45.38 % |
Profit YoY | 0 % |
Profit Margin (Sector Median: 1.8) | 17.93 % |
ROE (ROIC: 10.72) | 11.75 % |
Dividend Per Share (DPS) | 0.0 sen |
Dividend Yield (DY) | 0.0 % |
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
EPS | |
Trailing PE (Sector Median: 24.6) | |
Profit QoQ | |
Profit YoY | |
Profit Margin (Sector Median: 1.8) | |
ROE (ROIC: 10.79) | |
Altman Z |
Discounted Cash Flow (DCF) 5% Growth | |
Discounted Cash Flow (DCF) 10% Growth | |
Relative Valuation | |
Average Analysts FV based on 5 rating(s) |
Graham Formula | |
Graham Number | |
Net Tangible Asset (NTA) | 0.15 | Consistent QR FV |
Forward PE FV Calculator | |
Latest Profit (adjusted) [M] | 2.97 |
Expected Profit (Next QR) [M] | |
Expected Profit (After QR above) [M] | |
Expected Profit (After QR above) [M] | |
Estimated Fair Value |
Growth/Risk Fair Value Calculator | |
Expected growth (%) | |
Estimated downside / risk (%) | |
Estimated New DCF Fair Value |
Contract/Award Contribution Calculator | |
Contract/Award Value (in Million) | |
Estimated Contribution to Stock Price | |
Estimated New DCF Fair Value |
Profit-Based Calculator | |
Expected Profit (M) | |
for Year | |
Estimated New DCF Fair Value |
Revenue-Based Calculator | |
Expected Revenue (M) | |
for Year | |
Estimated New DCF Fair Value |
Market Pricing | |
Expected Profit (M) | 0 |
Expected Revenue (M) | 0 |
Expected Growth (%) | 0 |
No transaction in the last 2 months.
Market Cap: 297 M.
Number of Shares: 373 M.
Adjusted Float: 0%.
UMediC Group Berhad is an investment holding company. Through its subsidiaries, the Group is principally involved in the marketing and distribution of various branded medical devices and consumables. It is also engaged in developing, manufacturing, and marketing its medical consumables. The Group is an authorised distributor of multiple established international medical device companies including Philips, Mindray, GE, and Merit. The Group distributes its products to its customers comprising public and private hospitals, other healthcare service providers as well as non-medical business entities. The company was incorporated in 2002 and is headquartered in Pulau Pinang, Malaysia.
Sectors: Healthcare, Health Care Equipment & Services
Code: 0256
Website: https://www.umedichealthcare.com/
Related Links: Bursa | Annual Report | Announcement
No warrants listed